Rosuvas D 10mg Tablet

About

Rosuvastatin/Dapagliflozin is an innovative combination therapy designed to address the intertwined conditions of dyslipidemia and type 2 diabetes, both significant risk factors for cardiovascular disease. Rosuvastatin, a highly effective HMG-CoA reductase inhibitor (statin), plays a crucial role in lowering elevated LDL-cholesterol levels and reducing overall cardiovascular risk by inhibiting cholesterol synthesis in the liver. Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, operates by promoting the excretion of excess glucose through the urine, thereby lowering blood glucose levels independently of insulin. Beyond its glycemic control benefits, dapagliflozin has demonstrated substantial cardiovascular and renal protective effects, making this combination particularly valuable. This synergistic approach offers comprehensive management for patients with type 2 diabetes and dyslipidemia, aiming to improve glycemic control, optimize lipid profiles, and significantly reduce the risk of major adverse cardiovascular events and progression of renal disease.

Uses

• Management of type 2 diabetes mellitus.
• Reduction of elevated LDL-cholesterol.
• Lowering of blood glucose levels.
• Reduction of cardiovascular risk in diabetic patients.

Directions For Use

Take orally once daily, preferably in the morning, with or without food. Adhere strictly to your doctor's instructions.

Benefits

• Effectively lowers LDL-cholesterol.
• Improves glycemic control in type 2 diabetes.
• Reduces risk of major adverse cardiovascular events.
• Provides renal protection in diabetic patients.
• Promotes weight loss.
• Convenient single-pill combination for co-morbidities.

Side Effects

• Urinary tract infections
• Genital yeast infections
• Hypoglycemia (when used with insulin/sulfonylureas)
• Dehydration
• Dizziness
• Nausea
• Back pain
• Increased urination
• Dyslipidemia (rarely)
• Ketoacidosis (rare)
• Myalgia
• Elevated liver enzymes

Safety Measures

• Alcohol - Limit alcohol intake as it can increase the risk of hypoglycemia, ketoacidosis, and liver damage.
• Pregnancy - Not recommended during the second and third trimesters due to potential adverse effects on fetal kidney development.
• Breastfeeding - Not recommended during breastfeeding as it may pass into breast milk and harm the infant.
• Liver - Use with caution in patients with hepatic impairment; monitor liver function tests regularly.
• Kidney - Contraindicated in severe renal impairment or end-stage renal disease. Monitor renal function before and during treatment.
• Lung - Generally safe for use in patients with lung conditions; no specific precautions related to lung function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.